Balance Sheet ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 10/12/2025 GMT			5-day change	1st Jan Change
185.86 ^USD	+2.52%		+1.49%	-11.37%

12-09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
12-02	Icon survey reveals increasing clinical trial startup delays	RE

2d2f7e659b4d147ab7d7ad4.VuIJ7-QVgGrrnEopj8xoydM-l6j6W3Q3q-mR2MmHTiM.AYs9rKdd0Fzd_wMRw4pRmppN3NGoaD9hn5jkuZDTN3c9k16knUP0Bq3rPQ

Published financial data: ICON PUBLIC LIMITED COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.8B	5.48B	7.74B	8.12B	8.28B
Total Revenues	2.8B	5.48B	7.74B	8.12B	8.28B
Cost of Goods Sold, Total	1.98B	3.97B	5.52B	5.71B	5.84B
Gross Profit	820M	1.51B	2.22B	2.41B	2.44B
Selling General & Admin Expenses, Total	344M	588M	783M	776M	736M
Stock-Based Compensation (IS)	-	73.84M	-	-	-
Depreciation & Amortization - (IS)	66.13M	315M	570M	586M	488M
Other Operating Expenses, Total	410M	977M	1.35B	1.36B	1.22B
Operating Income	410M	534M	866M	1.05B	1.22B
Interest Expense, Total	-13.02M	-182M	-230M	-337M	-237M
Interest And Investment Income	2.72M	574K	2.34M	5.01M	8.61M
Net Interest Expenses	-10.3M	-182M	-227M	-332M	-229M
Income (Loss) On Equity Invest.	-366K	-2.16M	-3.14M	-383K	-
EBT, Excl. Unusual Items	399M	350M	636M	714M	991M
Restructuring Charges	-18.09M	-31.1M	-31.14M	-45.39M	-92.12M
Merger & Related Restructuring Charges	-	-124M	-39.7M	-44.18M	-29.57M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	381M	195M	565M	624M	869M
Income Tax Expense	47.88M	41.33M	59.41M	11.75M	77.71M
Earnings From Continuing Operations	333M	153M	505M	612M	791M
Net Income to Company	333M	153M	505M	612M	791M
Minority Interest	-633K	-	-	-	-
Net Income - (IS)	332M	153M	505M	612M	791M
Preferred Dividend and Other Adjustments	4.52M	-	-	-	-
Net Income to Common Incl Extra Items	328M	153M	505M	612M	791M
Net Income to Common Excl. Extra Items	328M	153M	505M	612M	791M
Per Share Items
Net EPS - Basic	6.2	2.28	6.2	7.46	9.6
Basic EPS - Continuing Operations	6.2	2.28	6.2	7.46	9.6
Basic Weighted Average Shares Outstanding	52.86M	67.11M	81.53M	82.1M	82.48M
Net EPS - Diluted	6.15	2.25	6.13	7.4	9.53
Diluted EPS - Continuing Operations	6.15	2.25	6.13	7.4	9.53
Diluted Weighted Average Shares Outstanding	53.28M	68.07M	82.47M	82.72M	83.03M
Normalized Basic EPS	4.7	3.26	4.87	5.43	7.51
Normalized Diluted EPS	4.67	3.21	4.82	5.39	7.46
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	476M	849M	1.44B	1.63B	1.71B
EBITA	429M	774M	1.33B	1.51B	1.57B
EBIT	410M	534M	866M	1.05B	1.22B
EBITDAR	506M	899M	1.49B	1.68B	1.75B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	12.57	21.25	10.52	1.88	8.94
Current Domestic Taxes	28.96M	18.47M	53.25M	80.43M	118M
Current Foreign Taxes	17.98M	83.48M	131M	16.72M	60M
Total Current Taxes	46.95M	102M	184M	97.15M	178M
Deferred Domestic Taxes	1.65M	553K	-6.17M	45.25M	-26.66M
Deferred Foreign Taxes	-727K	-61.17M	-119M	-131M	-73.88M
Total Deferred Taxes	927K	-60.62M	-125M	-85.4M	-101M
Normalized Net Income	249M	219M	397M	446M	619M
Interest on Long-Term Debt	-	-	-	337M	237M
Non-Cash Pension Expense	-326K	119K	-358K	-314K	-
Supplemental Operating Expense Items
Advertising Expense	7.02M	-	-	-	-
Selling and Marketing Expenses	7.02M	-	-	-	-
Net Rental Expense, Total	30.15M	49.9M	52.72M	45.72M	44.9M
Imputed Operating Lease Interest Expense	7.07M	23.96M	18.5M	28.09M	22.6M
Imputed Operating Lease Depreciation	23.08M	25.94M	34.22M	17.63M	22.3M
Stock-Based Comp., COGS (Total)	8.56M	18.55M	22.85M	26.6M	26.05M
Stock-Based Comp., SG&A Exp. (Total)	17.71M	41.46M	47.67M	29.07M	19.82M
Stock-Based Comp., Other (Total)	-	73.84M	-	-	-
Total Stock-Based Compensation	26.27M	134M	70.52M	55.67M	45.87M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	840M	752M	289M	378M	539M
Short Term Investments	1.73M	1.71M	1.71M	1.95M	-
Total Cash And Short Term Investments	842M	754M	290M	380M	539M
Accounts Receivable, Total	1.14B	1.97B	2.69B	2.74B	2.69B
Other Receivables	63.51M	107M	112M	157M	163M
Total Receivables	1.21B	2.07B	2.8B	2.9B	2.85B
Inventory	4.8M	5.8M	-	-	-
Prepaid Expenses	48.68M	109M	137M	132M	140M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	2.1B	2.94B	3.23B	3.41B	3.53B
Gross Property Plant And Equipment	781M	997M	904M	921M	1.08B
Accumulated Depreciation	-522M	-463M	-400M	-420M	-546M
Net Property Plant And Equipment	259M	535M	504M	502M	530M
Long-term Investments	20.3M	24.96M	32.63M	46.8M	57.95M
Goodwill	936M	9.04B	8.97B	9.02B	9.05B
Other Intangibles, Total	66.46M	4.71B	4.28B	3.86B	3.56B
Deferred Tax Assets Long-Term	12.7M	48.39M	76.93M	73.66M	74.76M
Other Long-Term Assets, Total	38M	89.19M	92.17M	78.47M	72.8M
Total Assets	3.44B	17.39B	17.19B	16.99B	16.88B
Liabilities
Accounts Payable, Total	102M	227M	205M	262M	335M
Accrued Expenses, Total	300M	737M	802M	718M	595M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	55.15M	55.15M	110M	29.76M
Current Portion of Leases	24.33M	49.95M	43.66M	36.41M	36.78M
Current Income Taxes Payable	12.18M	59.43M	41.78M	13.97M	55.26M
Unearned Revenue Current, Total	661M	1.32B	1.51B	1.65B	1.61B
Other Current Liabilities	25.39M	26.64M	35.26M	29.56M	129M
Total Current Liabilities	1.12B	2.48B	2.69B	2.83B	2.8B
Long-Term Debt	348M	5.38B	4.6B	3.67B	3.4B
Long-Term Leases	60.8M	159M	132M	126M	140M
Unearned Revenue Non Current	838K	735K	-	-	-
Pension & Other Post Retirement Benefits	10.4M	16.26M	13.03M	14.74M	-
Deferred Tax Liability Non Current	10.41M	1.09B	989M	899M	812M
Other Non Current Liabilities	30.51M	198M	264M	218M	209M
Total Liabilities	1.59B	9.32B	8.69B	7.75B	7.35B
Common Stock, Total	4.58M	6.64M	6.65M	6.7M	6.59M
Additional Paid In Capital	617M	6.73B	6.84B	6.94B	7.02B
Retained Earnings	1.26B	1.42B	1.82B	2.43B	2.72B
Comprehensive Income and Other	-34.34M	-89.8M	-170M	-142M	-229M
Total Common Equity	1.85B	8.07B	8.5B	9.24B	9.52B
Minority Interest	-	-	-	-	-
Total Equity	1.85B	8.07B	8.5B	9.24B	9.52B
Total Liabilities And Equity	3.44B	17.39B	17.19B	16.99B	16.88B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	52.79M	81.55M	81.72M	82.5M	80.76M
ECS Total Common Shares Outstanding	52.79M	81.55M	81.72M	82.5M	80.76M
Book Value / Share	35.05	98.91	103.98	112.02	117.92
Tangible Book Value	848M	-5.68B	-4.75B	-3.64B	-3.09B
Tangible Book Value Per Share	16.06	-69.67	-58.15	-44.09	-38.24
Total Debt	434M	5.65B	4.83B	3.94B	3.6B
Net Debt	-408M	4.89B	4.54B	3.56B	3.06B
Debt Equivalent of Unfunded Proj. Benefit Obligation	10.4M	8.27M	-5.08M	-3.92M	-
Debt Equivalent Oper. Leases	241M	399M	422M	366M	359M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	4.53M	2.37M	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	3.72M	3.72M	3.72M	3.72M	3.72M
Buildings, Total	84.2M	82.02M	70.88M	70.07M	66.13M
Machinery, Total	573M	643M	611M	652M	797M
Full Time Employees	13.21K	38.33K	41.1K	41.1K	41.9K
Part Time Employees	2.52K	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	7.15M	7.08M	20.56M	31.53M	35.66M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	332M	153M	505M	612M	791M
Depreciation & Amortization - CF	46.89M	75.48M	106M	126M	138M
Amortization of Goodwill and Intangible Assets - (CF)	19.23M	240M	463M	460M	350M
Depreciation & Amortization, Total	66.13M	315M	570M	586M	488M
Amortization of Deferred Charges, Total - (CF)	523K	12.89M	17.75M	16.4M	23.53M
(Gain) Loss From Sale Of Asset	141K	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-3.64M	891K	-	-	-
Asset Writedown & Restructuring Costs	5.41M	20.04M	28.77M	8.69M	15.73M
(Income) Loss On Equity Investments - (CF)	366K	2.16M	3.14M	383K	-
Stock-Based Compensation (CF)	26.27M	134M	70.52M	55.67M	45.87M
Other Operating Activities, Total	31.66M	56.15M	-81.46M	-3.57M	-21.94M
Change In Accounts Receivable	-181M	95.86M	-753M	-78.58M	9.39M
Change In Accounts Payable	26.49M	-	-	-	-
Change in Unearned Revenues	292M	-69.12M	193M	135M	-37.74M
Change In Income Taxes	-1.76M	-	-	-	-
Change in Other Net Operating Assets	-26.93M	108M	10.12M	-171M	-28.16M
Cash from Operations	568M	829M	563M	1.16B	1.29B
Capital Expenditure	-51.06M	-93.75M	-142M	-141M	-168M
Cash Acquisitions	-37.76M	-5.91B	-	-71.77M	-84.16M
Investment in Marketable and Equity Securities, Total	42.24M	-6.01M	-3.71M	-14.2M	-14.57M
Other Investing Activities, Total	-	-10M	-	-	-
Cash from Investing	-46.58M	-6.02B	-146M	-227M	-267M
Short Term Debt Issued, Total	350M	-	-	-	-
Long-Term Debt Issued, Total	-	5.91B	75M	370M	2.32B
Total Debt Issued	350M	5.91B	75M	370M	2.32B
Short Term Debt Repaid, Total	-350M	-	-	-	-
Long-Term Debt Repaid, Total	-	-878M	-875M	-1.26B	-2.68B
Total Debt Repaid	-350M	-878M	-875M	-1.26B	-2.68B
Issuance of Common Stock	13.2M	119M	35.84M	50.97M	36.19M
Repurchase of Common Stock	-175M	-	-99.98M	-	-500M
Other Financing Activities, Total	-46.54M	-31.18M	-34K	-16K	-13.09M
Cash from Financing	-208M	5.11B	-864M	-844M	-837M
Foreign Exchange Rate Adjustments	6.87M	-7.73M	-16.72M	-997K	-22M
Net Change in Cash	320M	-88.09M	-463M	89.33M	161M
Supplemental Items
Cash Interest Paid	13.06M	106M	211M	318M	197M
Cash Income Tax Paid (Refund)	27.6M	55.1M	116M	164M	141M
Levered Free Cash Flow	430M	936M	380M	955M	1.09B
Unlevered Free Cash Flow	438M	1.04B	506M	1.15B	1.22B
Change In Net Working Capital	-140M	-348M	533M	5.58M	-90.52M
Net Debt Issued / Repaid	0	5.03B	-800M	-895M	-360M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.07	3.21	3.13	3.82	4.5
Return on Total Capital	11.65	4.17	4	4.93	5.8
Return On Equity %	18.98	3.09	6.1	6.9	8.44
Return on Common Equity	18.9	3.09	6.1	6.9	8.44
Margin Analysis
Gross Profit Margin %	29.31	27.56	28.66	29.65	29.51
SG&A Margin	12.3	10.72	10.12	9.56	8.89
EBITDA Margin %	17.01	15.49	18.54	20.09	20.62
EBITA Margin %	15.33	14.11	17.17	18.54	18.96
EBIT Margin %	14.64	9.74	11.19	12.88	14.73
Income From Continuing Operations Margin %	11.9	2.79	6.53	7.54	9.56
Net Income Margin %	11.88	2.79	6.53	7.54	9.56
Net Avail. For Common Margin %	11.72	2.79	6.53	7.54	9.56
Normalized Net Income Margin	8.89	3.99	5.13	5.49	7.48
Levered Free Cash Flow Margin	15.38	17.07	4.91	11.76	13.21
Unlevered Free Cash Flow Margin	15.65	18.92	6.53	14.15	14.72
Asset Turnover
Asset Turnover	0.88	0.53	0.45	0.48	0.49
Fixed Assets Turnover	10.58	13.81	14.91	16.15	16.05
Receivables Turnover (Average Receivables)	2.67	3.52	3.33	2.99	3.05
Inventory Turnover (Average Inventory)	494.35	749.1	-	-	-
Short Term Liquidity
Current Ratio	1.87	1.19	1.2	1.21	1.26
Quick Ratio	1.82	1.14	1.15	1.16	1.21
Operating Cash Flow to Current Liabilities	0.51	0.33	0.21	0.41	0.46
Days Sales Outstanding (Average Receivables)	137.02	103.55	109.74	122.07	120
Days Outstanding Inventory (Average Inventory)	0.74	0.49	-	-	-
Average Days Payable Outstanding	14.53	15.1	14.28	14.94	18.74
Cash Conversion Cycle (Average Days)	123.23	88.94	-	-	-
Long Term Solvency
Total Debt/Equity	23.44	69.99	56.83	42.62	37.84
Total Debt / Total Capital	18.99	41.17	36.24	29.88	27.45
LT Debt/Equity	22.12	68.68	55.67	41.03	37.14
Long-Term Debt / Total Capital	17.92	40.41	35.5	28.77	26.94
Total Liabilities / Total Assets	46.15	53.6	50.55	45.61	43.58
EBIT / Interest Expense	31.46	2.93	3.77	3.11	5.14
EBITDA / Interest Expense	38.86	4.93	6.48	4.98	7.39
(EBITDA - Capex) / Interest Expense	34.93	4.41	5.86	4.56	6.68
Total Debt / EBITDA	0.86	6.28	3.24	2.35	2.06
Net Debt / EBITDA	-0.81	5.44	3.05	2.12	1.75
Total Debt / (EBITDA - Capex)	0.95	7.01	3.59	2.56	2.27
Net Debt / (EBITDA - Capex)	-0.9	6.08	3.37	2.32	1.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.3	95.93	41.24	4.89	1.99
Gross Profit, 1 Yr. Growth %	-1.71	84.24	46.88	8.53	1.5
EBITDA, 1 Yr. Growth %	-3.89	78.76	69.08	13.66	4.68
EBITA, 1 Yr. Growth %	-4.57	80.71	71.82	13.27	4.27
EBIT, 1 Yr. Growth %	-5.5	30.63	62.17	20.74	16.62
Earnings From Cont. Operations, 1 Yr. Growth %	-11.41	-53.99	229.87	21.18	29.26
Net Income, 1 Yr. Growth %	-11.14	-53.91	229.87	21.18	29.26
Normalized Net Income, 1 Yr. Growth %	-6.15	-11.86	81.56	12.29	38.85
Diluted EPS Before Extra, 1 Yr. Growth %	-9.43	-63.41	172.44	20.72	28.78
Accounts Receivable, 1 Yr. Growth %	20.36	71.85	36.78	1.98	-1.97
Inventory, 1 Yr. Growth %	50	20.83	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	-4.13	106.47	-5.69	-0.52	5.78
Total Assets, 1 Yr. Growth %	18.16	406.08	-1.16	-1.14	-0.66
Tangible Book Value, 1 Yr. Growth %	27.07	-770.42	-16.36	-23.47	-15.09
Common Equity, 1 Yr. Growth %	14.35	335.99	5.34	8.74	3.05
Cash From Operations, 1 Yr. Growth %	37.69	45.97	-32.06	106.11	10.82
Capital Expenditures, 1 Yr. Growth %	0.81	129.3	51.64	-1.03	19.45
Levered Free Cash Flow, 1 Yr. Growth %	63.62	112.73	-59.39	151.3	14.6
Unlevered Free Cash Flow, 1 Yr. Growth %	61.74	131.71	-51.21	127.14	6.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.81	39.76	66.36	21.72	3.43
Gross Profit, 2 Yr. CAGR %	2.69	34.77	64.75	26.26	4.95
EBITDA, 2 Yr. CAGR %	2.62	30.44	73.86	38.63	9.08
EBITA, 2 Yr. CAGR %	3.39	32.97	80.31	67.9	34.63
EBIT, 2 Yr. CAGR %	3.03	10.49	45.55	39.93	18.66
Earnings From Cont. Operations, 2 Yr. CAGR %	1.58	-36.16	23.19	99.93	25.15
Net Income, 2 Yr. CAGR %	1.49	-36	23.31	99.93	25.15
Normalized Net Income, 2 Yr. CAGR %	2.72	-9.57	26.5	42.78	24.86
Diluted EPS Before Extra, 2 Yr. CAGR %	2.18	-42.44	-0.16	81.35	24.69
Accounts Receivable, 2 Yr. CAGR %	21.28	43.82	53.32	18.11	-0.01
Inventory, 2 Yr. CAGR %	44.46	34.63	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	27.74	40.69	39.54	-3.14	2.58
Total Assets, 2 Yr. CAGR %	20.8	144.54	123.65	-1.15	-0.9
Tangible Book Value, 2 Yr. CAGR %	24.82	191.87	136.8	-19.99	-19.39
Common Equity, 2 Yr. CAGR %	16.89	123.28	114.31	7.03	5.86
Cash From Operations, 2 Yr. CAGR %	45.41	41.77	-0.42	18.33	51.13
Capital Expenditures, 2 Yr. CAGR %	2.71	55.15	86.47	22.5	8.73
Levered Free Cash Flow, 2 Yr. CAGR %	49.15	83.74	-7.05	1.02	69.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	47.58	90.76	6.32	5.27	55.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.74	28.29	40.26	42.65	14.75
Gross Profit, 3 Yr. CAGR %	3.89	24.78	38.69	43.35	17.4
EBITDA, 3 Yr. CAGR %	5.3	23.41	42.22	50.89	26.24
EBITA, 3 Yr. CAGR %	5.62	24.46	44.83	54.43	43.25
EBIT, 3 Yr. CAGR %	5.78	11.44	25.56	36.76	31.68
Earnings From Cont. Operations, 3 Yr. CAGR %	5.76	-21.99	10.37	22.52	72.88
Net Income, 3 Yr. CAGR %	5.69	-21.99	10.55	22.6	72.88
Normalized Net Income, 3 Yr. CAGR %	5.82	-2.45	14.08	21.57	41.46
Diluted EPS Before Extra, 3 Yr. CAGR %	6.23	-27.44	-3.35	6.36	61.8
Accounts Receivable, 3 Yr. CAGR %	20.86	36.22	41.43	33.83	11
Inventory, 3 Yr. CAGR %	29.7	36.11	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	16.66	49.91	23.13	24.66	-0.26
Total Assets, 3 Yr. CAGR %	16.97	94.74	80.81	70.37	-0.99
Tangible Book Value, 3 Yr. CAGR %	34.24	118.6	92.43	62.51	-18.39
Common Equity, 3 Yr. CAGR %	15.82	81.27	73.82	70.93	5.69
Cash From Operations, 3 Yr. CAGR %	14.03	45.6	10.94	26.91	15.77
Capital Expenditures, 3 Yr. CAGR %	4.52	24.66	53.97	50.97	21.48
Levered Free Cash Flow, 3 Yr. CAGR %	14.76	69.14	11.09	29.49	5.36
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.46	72.79	21.09	36.94	5.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.17	26.88	34.5	25.62	24.17
Gross Profit, 5 Yr. CAGR %	4.25	16.46	24.86	25.37	24.06
EBITDA, 5 Yr. CAGR %	7	17.48	28.65	29.28	27.9
EBITA, 5 Yr. CAGR %	7.48	18.06	29.57	30.28	29.11
EBIT, 5 Yr. CAGR %	7.79	10.8	20.14	22.07	22.76
Earnings From Cont. Operations, 5 Yr. CAGR %	6.81	-10.19	12.41	13.67	16.06
Net Income, 5 Yr. CAGR %	6.77	-10.19	12.41	13.67	16.18
Normalized Net Income, 5 Yr. CAGR %	7.37	2.57	13.61	13.61	18.28
Diluted EPS Before Extra, 5 Yr. CAGR %	9.15	-13.51	3.63	4.67	7.02
Accounts Receivable, 5 Yr. CAGR %	14.44	26.42	32.92	28.66	23.11
Inventory, 5 Yr. CAGR %	21.67	19.3	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	11.5	29.12	25.33	25.88	14.46
Total Assets, 5 Yr. CAGR %	14.88	56.95	51.59	48.48	42.15
Tangible Book Value, 5 Yr. CAGR %	50.84	83.58	68.46	46.23	35.87
Common Equity, 5 Yr. CAGR %	19.38	53.55	48.14	46.82	42.55
Cash From Operations, 5 Yr. CAGR %	15.27	26.18	8.02	34.01	25.54
Capital Expenditures, 5 Yr. CAGR %	0.53	17.09	26.03	23.79	33.97
Levered Free Cash Flow, 5 Yr. CAGR %	19.19	44.65	5.95	37.63	31.61
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.28	46.19	11.62	41.72	33.74